JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5551
Pioneer Bancorp
PBFS
$434M
| $88.1K | ﹤0.01% |
8,799
+1,236
| +16% | +$10.8K |
2019 Q3
17 quarters
|
|
|
HTY
5552
DELISTED
JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND
HTY
| $88K | ﹤0.01% |
+17,230
| New | +$76.6K |
2023 Q4
0 quarters
|
|
5553
iShares Morningstar Small-Cap Growth ETF
ISCG
$974M
| $88K | ﹤0.01% |
2,000
-3,975
| -67% | -$156K |
2023 Q2
2 quarters
|
|
5554
Vuzix
VUZI
$253M
| $87.9K | ﹤0.01% |
42,157
| – | – |
2020 Q4
12 quarters
|
|
|
SBDS
5555
DELISTED
Solo Brands Inc
SBDS
| $87.7K | ﹤0.01% |
356
| – | – |
2021 Q4
8 quarters
|
|
5556
Orchestra BioMed
OBIO
$373M
| $87.7K | ﹤0.01% |
9,606
| – | – |
2023 Q2
2 quarters
|
|
5557
MoonLake Immunotherapeutics
MLTX
$969M
| $87.4K | ﹤0.01% |
1,448
-274,150
| -99% | -$14.1M |
2022 Q4
4 quarters
|
|
5558
Global X MSCI Argentina ETF
ARGT
$709M
| $86.5K | ﹤0.01% |
+1,685
| New | +$75.8K |
2023 Q4
0 quarters
|
|
|
LBC
5559
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $86.3K | ﹤0.01% |
8,061
+1,332
| +20% | +$12K |
2018 Q1
23 quarters
|
|
5560
Invesco Municipal Opportunity Trust
VMO
$576M
| $85.9K | ﹤0.01% |
8,936
+8,935
| +893,500% | +$78.3K |
2023 Q1
3 quarters
|
|
5561
Pearson
PSO
$9.76B
| $85.2K | ﹤0.01% |
6,935
-6,414
| -48% | -$74.6K |
2014 Q3
37 quarters
|
|
5562
Bank7 Corp
BSVN
$534M
| $85.2K | ﹤0.01% |
3,116
+691
| +28% | +$16.4K |
2018 Q4
20 quarters
|
|
5563
Foghorn Therapeutics
FHTX
$146M
| $85K | ﹤0.01% |
13,176
-7,841
| -37% | -$33.8K |
2020 Q4
12 quarters
|
|
5564
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$219M
| $84.9K | ﹤0.01% |
2,209
+40
| +2% | +$1.49K |
2022 Q4
4 quarters
|
|
|
RERE
5565
ATRenew
RERE
$824M
| $84.7K | ﹤0.01% |
44,136
+41,295
| +1,454% | +$72.4K |
2023 Q2
2 quarters
|
|
|
CNTA
5566
DELISTED
Centessa Pharmaceuticals
CNTA
| $84.6K | ﹤0.01% |
10,630
+529
| +5% | +$3.55K |
2021 Q2
10 quarters
|
|
5567
Franklin Emerging Market Core Dividend Tilt Index ETF
DIEM
$95M
| $84.5K | ﹤0.01% |
3,406
-403
| -11% | -$9.41K |
2023 Q2
2 quarters
|
|
5568
ProShares UltraShort Bloomberg Crude Oil
SCO
$1.02B
| $84.3K | ﹤0.01% |
1,009
-4,652
| -82% | -$351K |
2020 Q3
13 quarters
|
|
5569
PUT
Legend Biotech
LEGN
$3.78B
| $84.2K | ﹤0.01% |
+1,400
| New | +$88.7K |
2023 Q4
0 quarters
|
|
5570
Kamada
KMDA
$478M
| $83.7K | ﹤0.01% |
+13,673
| New | +$68.9K |
2023 Q4
0 quarters
|
|
|
VOXX
5571
DELISTED
VOXX International Corporation Class A
VOXX
| $83.6K | ﹤0.01% |
7,830
| – | – |
2022 Q4
4 quarters
|
|
5572
CALL
Builders FirstSource
BLDR
$6.25B
| $83.5K | ﹤0.01% |
500
-2,700
| -84% | -$359K |
2022 Q4
4 quarters
|
|
5573
Fidelity Enhanced International ETF
FENI
$11.4B
| $83.4K | ﹤0.01% |
+3,147
| New | +$80.6K |
2023 Q4
0 quarters
|
|
|
ASG
5574
Liberty All-Star Growth Fund
ASG
$326M
| $83.1K | ﹤0.01% |
15,744
+3,917
| +33% | +$19.3K |
2023 Q3
1 quarter
|
|
5575
Franklin High Yield Corporate ETF
FLHY
$1.23B
| $82.8K | ﹤0.01% |
3,533
-77
| -2% | -$1.75K |
2023 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.